Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.


  • Glycosylation
  • Therapeutic proteins
  • Glycoprofiling
  • Glycosyltransferases
  • Glycoproteins
  • Glycosaminoglycans
  • Glyconutrients
  • Microbial glycobiology
  • Glycosidic bond

Related Conference of Glycoengineering

Glycoengineering Conference Speakers